Genome-Wide CRISPR Screen Identifies ELP5 as a Determinant of Gemcitabine Sensitivity in Gallbladder Cancer
Nature Communications - United Kingdom
doi 10.1038/s41467-019-13420-x
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC